Baqsimi Powder
Product Images NDC 85766-212

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Baqsimi (NDC 85766-212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This appears to be a table showing mean glucose levels in mg/dL over time (in minutes) with a reference to a medication called BAQSIMI. It indicates a decreasing trend in glucose levels from 216 mg/dL at the start to 50 mg/dL at the end. The specific details are not fully clear, but it seems to be related to monitoring glucose levels over time.*

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Ifu1 (Ifu1)

FDA Label Image

Ifu2 (Ifu2)

Shrink Wrap*

FDA Label Image

Ifu3 (Ifu3)

FDA Label Image

Ifu4 (Ifu4)

FDA Label Image

Ifu5 (Ifu5)

FDA Label Image

Ifu6 (Ifu6)

FDA Label Image

Ifu7 (Ifu7)

FDA Label Image

Label (Label)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.